Collectively, these data suggest that CD8+ T cells residing in the GBM core adopt a complex and partially dysfunctional phenotype characterised by augmented interferon signalling and inflammatory activation, which may underline their unexpected association with poorer clinical outcomes. The gene discussed is CD8A; the disease is glioblastoma.